ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · Real-Time Price · USD
67.37
-0.24 (-0.35%)
Mar 31, 2025, 3:37 PM EDT - Market open
ANI Pharmaceuticals Revenue
In the year 2024, ANI Pharmaceuticals had annual revenue of $614.38M with 26.20% growth. ANI Pharmaceuticals had revenue of $190.57M in the quarter ending December 31, 2024, with 44.75% growth.
Revenue (ttm)
$614.38M
Revenue Growth
+26.20%
P/S Ratio
2.13
Revenue / Employee
$684,923
Employees
897
Market Cap
1.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 614.38M | 127.56M | 26.20% |
Dec 31, 2023 | 486.82M | 170.43M | 53.87% |
Dec 31, 2022 | 316.39M | 100.25M | 46.38% |
Dec 31, 2021 | 216.14M | 7.66M | 3.67% |
Dec 31, 2020 | 208.48M | 1.93M | 0.93% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ANIP News
- 12 days ago - ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets - GlobeNewsWire
- 13 days ago - ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ® - GlobeNewsWire
- 17 days ago - ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label - GlobeNewsWire
- 27 days ago - ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe - GlobeNewsWire
- 4 weeks ago - ANI Pharmaceuticals, Inc. (ANIP) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - ANI Pharmaceuticals Expects Strong Start To 2025, On Back Of Cortrophin Gel And Generics, Lifts Annual Forecast - Benzinga
- 4 weeks ago - ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance - GlobeNewsWire
- 5 weeks ago - ANI Pharmaceuticals to Present at Raymond James' Institutional Investors and Leerink Partners Global Healthcare Conferences in March - GlobeNewsWire